She might not be of the age where this is all of interest to her:
Boots is enjoying a sales uplift thanks to its new erectile dysfunction treatment rivalling Viagra.
The pharmacy and beauty chain said sales at its retail healthcare arm, which includes over-the-counter medicines and treatments, were up almost 14pc in the three months to the end of August.
Boots specifically called out buoyant sales of its Viagra-alternative Sildenafil, which it started selling in early June.
It’s not rivalling, it’s not an alternative. It is. It’s simply the generic version of the very same drug.
Perhaps this is one of those times that age is a useful requirement for a journalist? You know, someone with the experience – either directly or as the partner in the exploitation of – the subject under discussion?